Cure My Disease

Don't miss your cure!

 Log in / Sign up

Doctors track Real-Life results of lung cancer drug in russia

NCT ID NCT05456867

Ongoing Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study is observing how the drug durvalumab works for patients with stage III non-small cell lung cancer in real Russian clinics, after they have completed chemo-radiation therapy. It aims to collect information on the drug's safety, how long patients stay on treatment, and what happens after they stop. The study is not testing a new treatment but gathering data from about 250 patients already receiving durvalumab as part of their standard care.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NSCLC (NON-SMALL CELL LUNG CARCINOMA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research Site

    Arkhangelsk, Russia

  • Research Site

    Chelyabinsk, Russia

  • Research Site

    Grozny, Russia

  • Research Site

    Irkutsk, Russia

  • Research Site

    Khanty-Mansiysk, Russia

  • Research Site

    Kostroma, Russia

  • Research Site

    Krasnodar, Russia

  • Research Site

    Krasnoyarsk, Russia

  • Research Site

    Moscow, Russia

  • Research Site

    Murmansk, Russia

  • Research Site

    Nizhny Novgorod, Russia

  • Research Site

    Novosibirsk, Russia

  • Research Site

    Perm, Russia

  • Research Site

    Saint Petersburg, Russia

  • Research Site

    Sochi, Russia

  • Research Site

    Surgut, Russia

  • Research Site

    Tomsk, Russia

  • Research Site

    Ufa, Russia

  • Research Site

    Vologda, Russia

  • Research Site

    Yaroslavl, Russia

  • Research Site

    Yekaterinburg, Russia

  • Research Site

    Yuzhno-Sakhalinsk, Russia

Conditions

Explore the condition pages connected to this study.

NSCLC (NON-SMALL CELL LUNG CARCINOMA)